the aid library

LIST OPTIONS

Filter

7790

External Link

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

Henao-Restrepo, A.M.; et al. (2016)

The Lancet. Published Online December 22, 2016 http://dx.doi.org/10.1016/S0140-6736(16)32621-6. Open Access

Download (623)

View PDF (916)

Recognizing, Managing, and Reporting Zika Virus Infections in Travelers Returning from Central America, South America, the Caribbean, and Mexico

Centers for Disease Control and Prevention (CDC) (2016) C_CDC

Article from the CDC Health Alert Network

Download (299)

View PDF (317)

Statement of guidance and recommendations to African Union Member States on the epidemic modelling of the COVID-19 pandemic

African Union; Africa CDC Centres for Disease Control and Prevention (2021) C1

Many African countries were amongst the most rapid to respond to the emerging threat of COVID-19, implementing large-scale interventions at very early stages of their epidemic. As demonstrated in this document using very simple models, this rapid mobilization and timeliness of implementing control m... more

Download (1163)

View PDF (3490)

Outbreak surveillance and response in humanitarian emergencies

World Health Organization (2012)

Download (297)

View PDF (607)

Monitoring mental health systems and services in the WHO European Region: Mental Health Atlas, 2017

World Health Organization WHO; Regional Office for Europe (2018) C_WHO

A stated objective of WHO’s European Mental Health Action Plan 2013–2020 is to ensure better information and knowledge for service planning, development, monitoring and evaluation, including requesting Member States to report on the indicators in the Plan. Progress towards achieving the int... more

Download (1286)

View PDF (1638)

ICRC operational security: staff safety in armed conflict and internal violence

Patrick Brugger ICRC (2009)

International Review of the Red Cross Volume 91 Number 874 June 2009

Download (309)

View PDF (353)

Baseline Study Report Female Genital Mutilation/Cutting and Child Marriage among the Rendille, Maasai, Pokot, Samburu and Somali Communities in Kenya

United Nations Children’s Fund (UNICEF) (2017) C_UNICEF

In recognition that Female Genital Mutilation (FGM) is not only a harmful practice but a violation of human rights, Kenya has adopted a robust legal framework. The country has ratified several international legal instruments that have become part of the Kenyan law as provided for in Article 2 of the... more

External Link

The Family and Disability in Ghana: Highlighting Gaps in Achieving Social Inclusion

Peprah Opoku,M.; et al. Disability, CBR & Inclusive Development Journal (DCIDJ) (2017) CC

There are social and environmental barriers faced by persons with disabilities which have been reported in literature. In discussing these barriers, attention is yet to be given to the support from families to members with disabilities. This study aimed to examine family support and its impact on th... more

Download (257)

View PDF (549)

Risk communication and community engagement: a compendium of case studies in times of COVID-19

World Health Organization WHO, Regional Office of Europe (2022) C_WHO

This collection of case studies on risk communication and community engagement (‎RCCE)‎ from 18 different country/area level public health partners in the WHO European Region provides evidence of numerous results achieved and lessons learned since the start of the COVID-19 pandemic. RCCE has not... more

Download (371)

View PDF (323)

Disease Surveillance, Emergency Preparedness and Response in Eastern and Southern Africa

World Bank, et al. (2021) CC

A Situational Assessment and Five-YearAction Plan for the Africa CDC Strengthening Regional Public Health Institutions and Capacity for Surveillance and Response Program

Download (231)

View PDF (351)

The Privacy, Confidentiality and Security Assessment Tool - Protecting personal health information

UNAIDS (Joint United Nations Programme on HIVAIDS); PEPFAR UNAIDS (Joint United Nations Programme on HIVAIDS); PEPFAR (2016) C2

UNAIDS 2019 / Guidance

Download (260)

View PDF (296)

Selecting digital contact tracing and quarantine tools for COVID-19 : guiding principles and considerations for a stepwise approach

World Health Organization WHO, Western Pacific Region (2020) CC

Contact tracing is a key component of the COVID-19 response, particularly as societies begin to lift non-pharmaceutical interventions. However, it is a time-consuming and resource-intensive effort that depends on a trained and motivated workforce. Emergent digital contact tracing and quarantine (‎... more

Download (2993)

View PDF (1278)

Principles and practices of drinking-water chlorination: a guide to strengthening chlorination practices in small-to mediumsized water supplies

World Health Organization (WHO) (2017) CC

This guide is intended for people involved in the management and operation of small- to mediumsized organized water supply systems. The content has been developed with particular consideration for operational-level personnel with responsibility for chlorination (for example, water treatment plant op... more

Download (467)

View PDF (693)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (465)

View PDF (681)

Status of Sexual and Reproductive Health and Rights in Zambia [Part 2]

Population Council, UNFPA, Government of Zambia Human Rights Commission, WLSA, and United Nations in Zambia (2017) C1

Comprehensive Sexuality Education and Adolescents Sexual and Reproductive Health

Download (287)

View PDF (344)

Environmentalism and Development in Catholic Social Teaching: a case of the Encyclical Laudato Si

Pavic, Z. ; Sundalic, A. Strossmayer J.J: et al. Research Gate (2016) C1

God. XXIX, BR. 2/2016. str. 323-334 In this paper an attempt has been made to contextualize the ecological dimension of contemporary Catholic social teaching. With this aim in mind, the authors discuss the merits of several theories and approaches (political economy approaches, ecological moderni... more

Download (1543)

View PDF (2156)

Contracting between faith-based and public health sector in Sub-Saharan Africa: an ongoing crisis? The cases of Cameroon, Tanzania, Chad and Uganda

Delphine Boulenger, Basile Keugoung & Bart Criel, Institute of Tropical Medicine, Antwerp Medicus Mundi International Network (MMI) (2009) C1

Download (358)

View PDF (448)

Bosnia and Herzegovina - National Drug Situation Report 2017

European Monitoring Centre for Drugs and Drug Addiction (2018) C2

External Link

South Africa Demographic and Health Survey 2016

National Department of Health - NDoH, Statistics South Africa, South African Medical Research Council SAMRC, and ICF (2019) CC

Large File: 12 MB!

Download (317)

View PDF (544)

NCDs and climate change: Shared opportunities for action

NCD Alliance (2016) CC

The policy brief focuses on four key areas for intervention - air pollution, energy, transport and food systems. Air pollution causes 7 million deaths annually, and is a leading cause of both NCDs and climate change, thus all interventions to reduce air pollution have a positive impact on both human... more